Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.ATS Corporation (ATS:CA) Q4 2026 Earnings Call Transcript
ATS Q4 Earnings Call Highlights
ATS (ATS) Q4 Earnings Lag Estimates
ATS Reports Fourth Quarter Fiscal 2026 Results
Is Nordson (NDSN) 7.3% Overvalued After Q2 FY2026? GAAP EPS $2.09 (miss vs $2.57), Adj. EPS $2.86 (beat), Revenue $740.8 million (beat vs $728.84 million) -- GF Score 93/100
Securitize Reports First Quarter 2026 Results
Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2026
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
ATS to Host Fourth Quarter Earnings Call Thursday May 28, 2026, at 8:30 a.m. Eastern
Genpact Declines 9.4% Since Beating Q1 Earnings & Revenue Estimates
Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
Celestica Surpasses Q1 Earnings Estimates on Solid CCS Demand
Will ATS (ATS) Beat Estimates Again in Its Next Earnings Report?
ATS (TSE:ATS) Trading Down 3.2% – What’s Next?
ATS Corporation (NYSE:ATS) Given Average Recommendation of “Hold” by Analysts
ATS Corporation (NYSE:ATS) Receives $35.00 Consensus PT from Brokerages
ATS to Participate in the TD Cowen Distinctive Industrials and Infrastructure Services Conference
Nordson Corp (NDSN) Q1 2026 Earnings Call Highlights: Record Sales and Strong Growth in Advanced Technology Solutions
ATS to Participate in the Raymond James Institutional Investors Conference